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Long term mortalityBackground: Short and midterm mortality of patients with osteoarthritis (OA) who have undergone total knee
arthroplasty (TKA) is generally lower than that of the general population. Due to an increasing number of
young patients who undergo TKA the expected lifetime of these patients is increasing. The purpose of this
study was to assess the causes of death and long-term mortality among Finnish TKA patients.
Methods: Standardizedmortality ratios (SMRs) for total and site specific causes of deathwere calculated for 9443
TKA patients operated on in 1980 to 1996 for OA and followed until 2012.
Results: The mean follow-up time was 14 years (maximum 33 years). During follow-up, 77% of the patients had
died. The all-cause SMR was 1.00. It was significantly lower than in the reference population (SMR 0.73) during
the first 10 years after operation, but higher during the next 10 years (SMR 1.23), and even more after 20 years
(SMR1.95). The SMR for cardiovascularmortalitywas 1.03 and accounted for 52% of all deaths. Significant excess
mortality was observed in diseases of the digestive tract (SMR 1.29). Deaths due to cardiovascular diseases,
Alzheimer's disease and dementia comprised 68% of all deaths that took place 10 years or later after TKA.
Conclusions: Themortality of TKA patients with OA is significantly reduced during the first 10 postoperative years
but exceeds the mortality of the general population after that. This trend should be taken into account when
young patients undergo a TKA.
Level of evidence: Observational study, III.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Mid-term mortality of patients with total knee arthroplasty (TKA)
for primary osteoarthritis (OA) in previous single andmulticenter stud-
ies has been reported to be the same [1], lower [2–4] or even higher [5]
than that of the general population. In a large US Medicare cohort the
hazard ratio for mortality of TKA patients at seven years compared
withmatched kneeOApatientswhohave not undergone a TKAwas sig-
nificantly reduced [6].
Results from the Swedish Knee Arthroplasty Register show that the
OA TKA patients have a reduced overall mortality during the first 12
post-operative years, after which it increases and become significantly
higher than in the general population. This increase was especially
strongly associatedwith patients younger than 55 years. Cardiovascular,
gastrointestinal, and urogenital diseases were largely responsible for
the higher mortality. The authors proposed that there may be a link be-
tween early onset of knee OA and increased mortality [7].spoo, Finland. Tel.: +358 40There is growing evidence that OA is associated with cardiovascular
diseases (CVDs) [8–10] which may relate to the long-term mortality of
TKA patients. Patients with radiologically verified OA of the hip or
knee have an increased risk of all cause mortality when followed up
for a median of 13 to 14 years [10,11].
TKA is essential for the treatment of severe pain and for the restitu-
tion of walking ability. Themortality of patients with OA of the knee un-
dergoing TKA may not exceed that of the general population, but this
consideration is hampered by the fact that the long-term impact of
TKA on all cause and disease specific mortality is not well known. The
purpose of this study of a Register was to assess how all disease and
main disease group specific late mortality deviates from those of the
general population over a long period of time.
2. Patients, materials and methods
The patient data were obtained from the Finnish Arthroplasty Regis-
ter covering the years 1980 to 1996. The dates and causes of death of the
cohort subjects were retrieved from Statistics Finland by record linkage
using the individual's personal identity code as the key. The coverage of
the cause-of-death statistics is virtually complete.
Table 1
Numbers of patients (n) with total knee arthroplasty by sex and age at operation and
number of person-years at risk up to the end of 2012.
Age (years) Men Women All
n Person-years n Person-years n Person years
30 to 39 6 22 6 14 12 36
40 to 49 37 177 47 226 84 403
50 to 59 221 1134 528 2307 749 3441
60 to 69 787 5405 2801 16,613 3589 22,018
70 to 79 821 11,100 3572 46,173 4393 57,273
≥80 129 7242 488 41,294 617 48,536
















Fig. 1. Standardized mortality ratios (SMRs) with 95% confidence limits for all diseases
during 25 years of follow-up among 9443 patients with a total knee arthroplasty for
osteoarthritis.
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ated on for OA were included in the final analysis. The follow-up of the
patients started from the first primary TKA. Mortality risk related to
later revisions were not studied separately. The patient data have
been described in detail previously [12]. All patients had received anun-
constrained TKA, 79% had cobalt chromiummolybdenum and 21% tita-
nium aluminium vanadinium alloy parts. The percentage of cemented
component fixation on the femoral sidewas 46 and on the tibial side 57.
The standardizedmortality ratio (SMR)was expressed as the ratio of
observed and expected number of cases. The expected numbers of
deaths were calculated by multiplying the number of person-years in
each stratum by the corresponding average mortality rate throughout
Finland during the period of observation. The number of observed
cases for each cause of death and person-year during the follow-up
was stratified by gender, calendar period, five year age group, and theTable 2
Observed number of total deaths (Obs), standardizedmortality ratio (SMR) 95% confidence inte
and number of postoperative years.
Time since TKA surgery (completed years) Men
Obs SMR (95% CI)
0–1 96 0.50 (0.41–0.61⁎⁎⁎)
2–9 680 0.84 (0.78–0.90⁎⁎⁎)
10–19 758 1.22 (1.13–1.30⁎⁎⁎)
20+ 79 1.65 (1.31–2.05⁎⁎⁎)
Total 1613 0.97 (0.92–1.01)
⁎⁎⁎ p b 0.001.follow-up time since the TKA operation. The calendar periods were
1980 to 1985, 1986 to 1991, 1992 to 1997, 1998 to 2002, 2003 to
2007, and 2008 to 2012. The closing date was December 31, 2012. The
follow-up categories were b1, 1 to 9.99, 10 to 19.99, and ≥20 years
since the operation. The 95% confidence intervals (95% CIs) were de-
fined assuming that the number of observed cases followed a Poisson
distribution.
The list of causes of death based on International Classification of
Diseases (ICD) versions: ICD-8, ICD-9, and ICD-10. Of the main catego-
ries cancer, cardiovascular disease (CVD), respiratory, genitourinary, di-
gestive system, dementia, Alzheimer's disease, and accidental deaths
were analyzed. This study was approved by the National Institute for
Health and Welfare, decision THL/1615/5.05.00/2013. The study sub-
jects were not contacted and therefore no informed consents were re-
quired according to the Finnish regulations.
3. Results
Total number of person-years was 131,708 and 79% of the patients were females
(Table 1). A total of 7254 (77%) of the TKA patients had died by the closing date. The
mean follow-up time was 14 years (Table 1).
All-cause mortality was significantly reduced during the first 10-year follow-up peri-
od, but it was significantly increased during the second follow-up decade and reached the
level of mortality of the normal population by 11 years. After 20 years of follow-up, the
mortality of the study group exceeded significantly themortality of the normal population
(Fig. 1, Table 5). There were 1020 fewer deaths than expected during the first decade of
follow-up, and an excess of 1005 cases after that period (Table 3). Females and males
had similar SMRs throughout the follow-up period (Table 2).
Overall cancer mortality was significantly reduced but showed an increasing trend
over time and reached the mortality of the normal population by the 17th postoperative
year (Fig. 2, Table 3). Cancer deathswere reduced by 16.3% during thefirst 10 year period
and by 1.0% after that (Table 3).
Respiratory tract cancermortality was especially low: the SMR of all patientswas 0.68
(95% Cl 0.57 to 0.81); 0.61 (95% Cl 0.46 to 0.78) formales and 0.78 (95% Cl 0.59 to 0.99) for
females. Mortalities from colon, breast and cervical and uterine cancer were significantly
decreased as well. Late mortality in prostate and hematopoietic cancers was similar with
that of the average population.
Cardiovascular disease was themost common cause of death andmortality increased
linearly during thewhole follow-up time. It reached the level of the normal population by
the 10th postoperative year and remained higher than for the general population during
the remaining follow-up time (Fig. 3, Table 5). Cardiovascular disease accounted for 52%
of all causes of death. During the first 10 years there was a 40.2% reduction from the ex-
pected value, but after that cardiovascular deaths comprised 631 numerical excess deaths,
which is 62.8% of all numerical excess deaths (Table 3).Men andwomen presentedwith a
similar trend of CVDmortality: the SMRs during thefirst postoperative year were 0.61 and
0.52, from two to nine years 0.86 and 0.76, from 10 to 19 years 1.37 and 1.30, and after
20 years 1.68 and 2.06, respectively.
Mortality in respiratory diseases was lower during the first 10 years (Tables 4 to 5),
after which it was in accordance with the general population both for males and females.
Mortality from Alzheimer's disease and dementia was also significantly lower during
thefirst 10 years after surgery, afterwhich it showed a steep increase (Tables 4 to 5). There
was a significant excess of deaths in these diseases among females (SMR 1.56, 95% Cl 1.27
to 1.87) but not among males (SMR 0.96, 95% CI 0.79 to 1.14). This group of diseases was
the second highest cause of deathwith 18.7% after 10 yearswith a numerical excess of 43.5
deaths (Table 3).
A similar trend was observed concerning the mortality due to genitourinary and di-
gestive tract diseases. The mortality in digestive tract diseases was significantly increased
(SMR 1.29) (Tables 4 to 5). The incidence of accidental deathswas in linewith the normal
population (Tables 4 to 5). Therewas, however, a numerical excess of 16.6 deaths after the
20th postoperative year (Table 3).rval (95% CI) among 9443 patientswith total knee arthroplasty for osteoarthritis by gender
Women All patients
Obs SMR (95% CI) Obs SMR (95% CI)
218 0.50 (0.44–0.56⁎⁎⁎) 314 0.50 (0.45–0.55⁎⁎⁎)
1822 0.77 (0.73–0.80⁎⁎⁎) 2502 0.78 (0.75–0.81⁎⁎⁎)
3098 1.23 (1.19–1.27⁎⁎⁎) 3856 1.23 (1.19–1.26⁎⁎⁎)
503 2.00 (1.83–2.17⁎⁎⁎) 582 1.95 (1.79–2.11⁎⁎⁎)
















Fig. 2. Standardized mortality ratios (SMRs) with 95% confidence limits for cancer during
















Fig. 3. Standardizedmortality ratios (SMRs) with 95% confidence limits for cardiovascular
disease during 25 years of follow-up among 9443 patients with total knee arthroplasty for
osteoarthritis.
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Total knee arthroplasty is usually indicated for patients with end-
stage OA which causes severe pain and a compromised walking ability.
Knee OA as such is associated with increased mortality. There is data,
derived from population-based epidemiologic and clinical studies,
which provide some evidence that radiographic and symptomatic OA,
particularly of the knees, is associated with increased mortality related
especially to acute CVD and gastrointestinal causes [8]. Hip and knee
OA patients with moderate symptoms after a median of 13 to 14 years
follow-up have been shown to have significantly increased all-cause
mortality related to the severity of the walking disability [10,11]. Re-
stricted walking before the TKA (inability to walk or ability to walk
only indoors) is a strong predictor of postoperative mid-termmortality
among patients above the age of 75 [13].
Due to surgical stress, the postoperative mortality of total joint
arthroplasty (TJA) patients increases during the first 22 to 41 days
after surgery [14]. This excess changes rapidly to a reduced risk of mor-
tality. Themortality ratio during thefirst postoperative year in our study
was also only half of the expected population value. This reduction
pertained to almost all disease related groups for the next 10 years.
The “healthy patient” effect, i.e. preoperative selection of the patients
has generally been regarded as a cause for this phenomena. The
“healthy patient” effect is undefined and its duration is not known.
There may be several reasons for this reduction. TKA may have a
cardioprotective effect due to improved cardiovascular fitness [15].
Ravi et al. studied a propensity score matched cohort of 153 matchedTable 3
Observed (Obs) vs. expected (Exp) deaths before and after 10 years of TKA surgery among
9443 patients with total knee prosthesis for osteoarthritis.
Time since TKA surgery
Cause of death b10 years ≥10 years
Obs Exp Obs–Exp Obs Exp Obs–Exp
Cancer 555 720.7 −165.7 523 533.3 −10.3
Cardiovascular 1453 1862.9 −409.9 2339 1708.1 +630.9
Respiratory 167 316.2 −149.1 236 263.4 +11.3
Alzheimer, dementia 162 306.2 −144.2 700 512.3 +187.7
Genitourinary 34 52.1 −18.1 77 46.9 +30.1
Digestive organs 119 120.4 −1.4 177 108.4 +68.7
Accidents, violence 119 126.1 −7.1 137 113.3 +23.7
All causes 2816 3835.7 −1019.7 4438 3433.5 +1004.6pairs of participants with moderate or severe OA. Over a median
follow-up period of seven years, TJA (94 TKA, 49 total hip arthroplasty
(THA)) was associated with a significantly reduced rate of CVD events
compared to matched controls; for TKA patients the hazard ratio was
0.46 (0.29 to 0.75) [16]. Furthermore, the reduction in chronic pain
may be another reason why mortality rates decrease in the first
10 years after TKA.
Both pre- and postoperatively TKA patients undergo a dental exam-
ination and dental treatment to prevent hematogenous dissemination
of oral biofilm bacteria to the prosthesis and possible infection. Peri-
odontitis imparts an increased risk of future CVD [17]. Patients who re-
ceive knee implants are also likely to be under increased medical
surveillance in general and started on medication for CVDs. The protec-
tive effect of medication may, at least partly, explain the reduction in
mortality. The role of each factor requires further studies.
The growingmortality of the TKApatients after 10 years of follow-up
starts to exceed the gain of lifetime seen before that period. Reasons for
the excess mortality after 10 years are not known. Walking disability
might be a commondenominator for these phenomena. It predictsmor-
tality among knee OA patients [10,11], preoperatively [13], and even
postoperatively as shown by Lizaur-Utrilla in a 10 years follow-up
study [4]. Deterioration of the walking capacity of TKA patients after
10 years has not been studied. However the subjective outcomes of
TKA patients during the first ten years of surgery were worse than the
objective outcomes. Rat et al. studied the quality of life among OA TJA
patients three and 10 years after surgery and observed that scores for
pain, mental health, and social dimensions were lower than for theTable 4
Observed number of deaths (Obs), standardizedmortality ratio (SMR) and 95% confidence
interval (95% CI) among 9443 patients with total knee prosthesis for osteoarthritis in the
main disease groups.
Cause of death TKA patients
Obs SMR 95% CI
Cancer 1078 0.86 0.81–0.91⁎⁎⁎
Cardiovascular 3792 1.03 1.00–1.06⁎
Respiratory 403 0.75 0.67–0.82⁎⁎⁎
Alzheimer, dementia 862 1.06 0.99–1.13
Genitourinary 111 1.12 0.92–1.33
Digestive system 296 1.29 1.15–1.44⁎⁎⁎
Accidents and violence 234 1.10 0.97–1.25
All causes 7254 1.00 0.98–1.02
⁎ p b 0.05.
⁎⁎⁎ p b 0.001.
Table 5
Observed number of deaths (Obs) and standardizedmortality ratio (SMR) with 95% confidence intervals (95% CI) among 9443 patients with total knee prosthesis for osteoarthritis in the
main disease groups by the completed follow-up time.
Cause of death Time since TKA surgery (completed years)
0–1 2–9 10–19 ≥20
Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
Cancer 59 0.43 0.33–0.55⁎⁎⁎ 496 0.85 0.78–0.92⁎⁎⁎ 468 0.96 0.88–1.05 55 1.20 0.91–1.56
Cardiovascular 180 0.78 0.74–0.82⁎⁎⁎ 1273 0.78 0.74–0.82⁎⁎⁎ 2045 1.31 1.25–1.36⁎⁎⁎ 294 2.00 1.78–2.23⁎⁎⁎
Respiratory 10 0.22 0.11–0.40⁎⁎⁎ 157 0.58 0.49–0.67⁎⁎⁎ 215 1.02 0.89–1.16 21 1.51 0.94–2.31
Alzheimer, dementia 1 0.03 0.00–0.18⁎⁎⁎ 161 0.59 0.51–0.68⁎⁎⁎ 570 1.24 1.14–1.34⁎⁎⁎ 130 2.47 2.07–2.91⁎⁎⁎
Genitourinary 4 0.50 0.14–1.28 30 0.68 0.46–0.96⁎ 64 1.48 1.14–1.88⁎⁎ 13 3.56 1.90–6.09⁎⁎⁎
Digestive system 12 0.65 0.34–1.13 107 1.05 0.86–1.25 159 1.60 1.36–1.86⁎⁎⁎ 18 2.01 1.19–3.17⁎
Accidents and violence 22 1.01 0.63–1.53 97 0.93 0.76–1.13 118 1.14 0.94–1.34 19 1.94 1.17–3.02⁎
All causes 314 0.50 0.45–0.55⁎⁎⁎ 2502 0.78 0.75–0.81⁎⁎⁎ 3856 1.23 1.19–1.26⁎⁎⁎ 582 1.95 1.79–2.10⁎⁎⁎
⁎ p b 0.05.
⁎⁎⁎ p b 0.001.
165T. Visuri et al. / The Knee 23 (2016) 162–166reference population at the 10-year follow-up [18]. Self reported func-
tion and pain of TKA patients had worsened at 10 years compared to
their situation at two years [19].
A similar mortality pattern has been observed among OA patients
who have undergone conventional metal-on-polyethylene THA: the
SMR increased from 0.37 during the first postoperative year to 1.38 by
20 years [20].
In contrast to the time trend of other disease groups, cancer deaths
increased only slightly during the whole follow-up time. Meta-
analyses show that after amean of 4.5 to 5.1 years, the overall standard-
ized cancer ratio (SIR) or cancer among TKApatientswithOA is 0.94 and
among patients operated on for all indications 0.97 [21,22]. In our
cohort the SIR at a mean of 5.5 years of follow-up was 0.98. The SIRs
of hematopoietic cancers (1.26) and of prostatic cancer (1.48) were in-
creased [12], but after longer follow-up timemortality in these diseases
was in line with the general population. Although results based on can-
cer incidence and cancer-related mortality are not totally comparable,
SMRs observed in this study and SIRs published earlier from the same
cohort [12] with 80,000 less person-years, confirm that TKA does not
carry any significantly increased overall cancer risk.
The incidence of respiratory tract cancerwas lower in this study than
has been previously published [12]. Heavy tobacco smokingwas associ-
ated with a decreased risk of knee OA in a comparison with never-
smoking (OR 0.2; 95% CI 0.1 to 0.5) [23]. A large register study showed
an independent inverse association between smoking and the risk of re-
ceiving a TJA. Male smokerswere 30% less likely and female smoker 40%
less likely than never smokers to undergo TJA surgery [24]. Smoking
seems to have a preventive effect on the development of OA. It has
been suggested that activation of α7 nicotinic acetylcholine receptors
prevents monosodium iodoacetate-induced OA in rats [25]. However,
it might as well be that smokers just do not go to the doctor as much
as non-smokers. Presumed small number of smokers in our cohort
may, in fact, explain the low mortality rate in respiratory and perhaps
other diseases, as well.
Cardiovascular disease was the main cause of death and reason for
the increased mortality after 20 years. OA and CVDs share common
risk factors. In a cohort of 23,570 patients cardiovascular risk factors
were linked with registers of OA-related arthroplasty data. The risk
ratio was significantly associated with the severity of CVD from the sec-
ond lowest to the highest disease severity quartile [9]. A large prospec-
tive and 10-years longitudinal study showed that OA was an
independent predictor of CVD comparedwith age and sexmatched indi-
viduals especially among older men and younger and older women. The
risk was elevated by 26% among individuals who underwent total joint
replacement [26]. Self- reported prevalence of OA was 35.3% in the US
national health survey from 1999 to 2008 and they had higher odds for
CVDs (OR 1.53) compared with subjects without OA [27]. After median
of 14.4 follow-up years Hoeven et al. concluded that the patients aged
55 years and older with knee OA had not an increased risk of CVD buttherewas a close relationshipwith their disability andOA [28]. Afterme-
dian of 14 years follow-up, 1163 patients with hip or knee OA had an ex-
cess of all-cause mortality compared with the general population.
Particularly CVDs were associated with excess mortality (SMR 1.71).
Mortality was related to increasing age, male sex, self-reported history
of diabetes, cancer, CVD and walking disability; the more severe the
walking disability, the higher risk of death [10]. Of the 2156 participants
whowere over 55 years of age andhad at leastmoderately severe symp-
tomatic hip/knee OA, 57.3% died and 38.1% experienced cardiovascular
events after amedian of 13.2 years. Low function scores andwalking dis-
ability were independently associated with an increased all-cause mor-
tality [11].
The main objective of this study was to compare the mortality pat-
tern of TKA patients with that of the general population. Data on preop-
erative comorbidity, socioeconomic status or life habits of our patients
were not available. Bias caused by selection of the patients and postop-
erative medical interventions may have covered the influence of the
prosthesis itself on the mortality.
Themortality pattern of TKA patients deviates from that of the normal
population: it is reduced during the first 10 postoperative years, but starts
a linear increase soon after surgery reaching that of the general popula-
tion at that time. The reasons for the late mortality excess in our cohort
are not known. Alzheimer's disease and dementia, and genitourinary dis-
eases were associated with increased mortality after 20 years. In theory,
TKA induced wear particles in circulation might expose to systemic neu-
rological diseases such as Alzheimer's disease and dementia. However,
we are not aware of any potential pathological mechanism behind this.
Among accidents complications, e.g., periprosthetic fractures and septic
prosthetic joint infectionsmay have had small influence on this phenom-
enon. After the 20th postoperative year, the SMR for accidental mortality
was 1.94, but the number of deaths was only 19. In future TKA patients
will be younger than today. During 10 years extending from 1998 to
2007 the number of TKA patients under 55 years of age in Sweden in-
creased five-fold and TKA is now the preferred treatment method for
young OA patients [29]. In Finland, the annual cumulative incidence of
TKAs in the age group of 30 to 59 years has increased 130-fold from
1980 to 2006 among patients operated on for OA [30]. Thus, much longer
follow-up times are to be expected and the comorbidity of these patients
and their increased long-term mortality must be taken into account.
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